Literature DB >> 30181176

Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia.

Gabriel Bretones1, Miguel G Álvarez1, Javier R Arango1, David Rodríguez1, Ferran Nadeu2, Miguel A Prado3, Rafael Valdés-Mas1, Diana A Puente1, Joao A Paulo3, Julio Delgado2,4,5, Neus Villamor2,4,5, Armando López-Guillermo2,4,5, Daniel J Finley3, Steven P Gygi3, Elías Campo2,4,5,6, Víctor Quesada1,5, Carlos López-Otín1,5.   

Abstract

Genomic studies have recently identified RPS15 as a new driver gene in aggressive and chemorefractory cases of chronic lymphocytic leukemia (CLL). RPS15 encodes a ribosomal protein whose conserved C-terminal domain extends into the decoding center of the ribosome. We demonstrate that mutations in highly conserved residues of this domain affect protein stability, by increasing its ubiquitin-mediated degradation, and cell-proliferation rates. On the other hand, we show that mutated RPS15 can be loaded into the ribosomes, directly impacting on global protein synthesis and/or translational fidelity in a mutation-specific manner. Quantitative mass spectrometry analyses suggest that RPS15 variants may induce additional alterations in the translational machinery, as well as a metabolic shift at the proteome level in HEK293T and MEC-1 cells. These results indicate that CLL-related RPS15 mutations might act following patterns known for other ribosomal diseases, likely switching from a hypo- to a hyperproliferative phenotype driven by mutated ribosomes. In this scenario, loss of translational fidelity causing altered cell proteostasis can be proposed as a new molecular mechanism involved in CLL pathobiology.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30181176      PMCID: PMC6410914          DOI: 10.1182/blood-2017-09-804401

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  64 in total

1.  Emerging therapeutics targeting mRNA translation.

Authors:  Abba Malina; John R Mills; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

2.  The evolutionary biography of chronic lymphocytic leukemia.

Authors:  Xose S Puente; Carlos López-Otín
Journal:  Nat Genet       Date:  2013-02-24       Impact factor: 38.330

Review 3.  More than just scanning: the importance of cap-independent mRNA translation initiation for cellular stress response and cancer.

Authors:  Rafaela Lacerda; Juliane Menezes; Luísa Romão
Journal:  Cell Mol Life Sci       Date:  2016-12-02       Impact factor: 9.261

4.  Specific functional interactions of nucleotides at key -3 and +4 positions flanking the initiation codon with components of the mammalian 48S translation initiation complex.

Authors:  Andrey V Pisarev; Victoria G Kolupaeva; Vera P Pisareva; William C Merrick; Christopher U T Hellen; Tatyana V Pestova
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

Review 5.  Ribosomal proteins as novel players in tumorigenesis.

Authors:  A de Las Heras-Rubio; L Perucho; R Paciucci; J Vilardell; M E LLeonart
Journal:  Cancer Metastasis Rev       Date:  2014-03       Impact factor: 9.264

6.  Ribosomopathies and the paradox of cellular hypo- to hyperproliferation.

Authors:  Kim De Keersmaecker; Sergey O Sulima; Jonathan D Dinman
Journal:  Blood       Date:  2015-01-09       Impact factor: 22.113

7.  Non-coding RNA: what is functional and what is junk?

Authors:  Alexander F Palazzo; Eliza S Lee
Journal:  Front Genet       Date:  2015-01-26       Impact factor: 4.599

8.  Altered translation of GATA1 in Diamond-Blackfan anemia.

Authors:  Leif S Ludwig; Hanna T Gazda; Jennifer C Eng; Stephen W Eichhorn; Prathapan Thiru; Roxanne Ghazvinian; Tracy I George; Jason R Gotlib; Alan H Beggs; Colin A Sieff; Harvey F Lodish; Eric S Lander; Vijay G Sankaran
Journal:  Nat Med       Date:  2014-06-22       Impact factor: 53.440

9.  Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells.

Authors:  Michael Ramirez; Satwik Rajaram; Robert J Steininger; Daria Osipchuk; Maike A Roth; Leanna S Morinishi; Louise Evans; Weiyue Ji; Chien-Hsiang Hsu; Kevin Thurley; Shuguang Wei; Anwu Zhou; Prasad R Koduru; Bruce A Posner; Lani F Wu; Steven J Altschuler
Journal:  Nat Commun       Date:  2016-02-19       Impact factor: 14.919

10.  The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling.

Authors:  T Girardi; S Vereecke; S O Sulima; Y Khan; L Fancello; J W Briggs; C Schwab; J Op de Beeck; J Verbeeck; J Royaert; E Geerdens; C Vicente; S Bornschein; C J Harrison; J P Meijerink; J Cools; J D Dinman; K R Kampen; K De Keersmaecker
Journal:  Leukemia       Date:  2017-07-24       Impact factor: 11.528

View more
  17 in total

1.  Clonal dynamics in chronic lymphocytic leukemia.

Authors:  Catherine Gutierrez; Catherine J Wu
Journal:  Blood Adv       Date:  2019-11-26

Review 2.  Clonal dynamics in chronic lymphocytic leukemia.

Authors:  Catherine Gutierrez; Catherine J Wu
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 3.  Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance.

Authors:  Amr R Elhamamsy; Brandon J Metge; Heba A Alsheikh; Lalita A Shevde; Rajeev S Samant
Journal:  Cancer Res       Date:  2022-07-05       Impact factor: 13.312

Review 4.  Understanding CLL biology through mouse models of human genetics.

Authors:  Elisa Ten Hacken; Catherine J Wu
Journal:  Blood       Date:  2021-12-23       Impact factor: 25.476

5.  Hallmarks of ribosomopathies.

Authors:  Kim R Kampen; Sergey O Sulima; Stijn Vereecke; Kim De Keersmaecker
Journal:  Nucleic Acids Res       Date:  2020-02-20       Impact factor: 16.971

6.  Defects in mRNA Translation in LRRK2-Mutant hiPSC-Derived Dopaminergic Neurons Lead to Dysregulated Calcium Homeostasis.

Authors:  Jungwoo Wren Kim; Xiling Yin; Aanishaa Jhaldiyal; Mohammed Repon Khan; Ian Martin; Zhong Xie; Tamara Perez-Rosello; Manoj Kumar; Leire Abalde-Atristain; Jinchong Xu; Li Chen; Stephen M Eacker; D James Surmeier; Nicholas T Ingolia; Ted M Dawson; Valina L Dawson
Journal:  Cell Stem Cell       Date:  2020-08-25       Impact factor: 24.633

7.  RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia.

Authors:  Stavroula Ntoufa; Marina Gerousi; Stamatia Laidou; Fotis Psomopoulos; Georgios Tsiolas; Theodoros Moysiadis; Nikos Papakonstantinou; Larry Mansouri; Achilles Anagnostopoulos; Niki Stavrogianni; Sarka Pospisilova; Karla Plevova; Antonios M Makris; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Blood Adv       Date:  2021-07-13

8.  An antisense circular RNA circSCRIB enhances cancer progression by suppressing parental gene splicing and translation.

Authors:  Jian Ma; William W Du; Kaixuan Zeng; Nan Wu; Ling Fang; Juanjuan Lyu; Albert J Yee; Burton B Yang
Journal:  Mol Ther       Date:  2021-08-06       Impact factor: 12.910

Review 9.  Tumor Suppressors in Chronic Lymphocytic Leukemia: From Lost Partners to Active Targets.

Authors:  Giacomo Andreani; Giovanna Carrà; Marcello Francesco Lingua; Beatrice Maffeo; Mara Brancaccio; Riccardo Taulli; Alessandro Morotti
Journal:  Cancers (Basel)       Date:  2020-03-09       Impact factor: 6.639

10.  Ancient Evolutionary Origin of Intrinsically Disordered Cancer Risk Regions.

Authors:  Mátyás Pajkos; András Zeke; Zsuzsanna Dosztányi
Journal:  Biomolecules       Date:  2020-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.